Michael Sefton receives $1.1M from JDRF for type 1 diabetes research

University of Toronto professor Michael Sefton (ChemE, IBBME) has been presented with a major research award from international diabetes foundation JDRF to advance treatment research for type 1 diabetes (T1D). The funding, valued at approximately $1.1 million ($845,135 USD), supports a three-year study at the University of Toronto’s Institute of Biomaterials & Biomedical Engineering (IBBME) to explore an experimental treatment that involves transplanting healthy pancreatic cells into patients living with the disease.

Read the full story